Targeting prokaryotic enzymes in the eukaryotic pathogen cryptosporidium

Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development

Volumn , Issue , 2011, Pages 271-285

  Gorla, Suresh Kumar ^a   Johnson, Corey ^a   Khan, Jihan ^a   Sun, Xin ^a   Sharling, Lisa ^b   Striepen, Boris ^b   Hedstrom, Lizbeth ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Cryptosporidium; Dinucleotide site inhibitors; Horizontal gene transfer; Inosine monophosphate (IMP) dehydrogenase; NAD; Purine biosynthesis

Indexed keywords

EID: 84883942391     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527633883.ch14     Document Type: Chapter

References (40)

1. Snelling,W.J., Xiao, L., Ortega-Pierres, G., Lowery, C.J., Moore, J.E. et al. (2007) Cryptosporidiosis in developing countries. J. Infect. Dev. Ctries, 1, 242-256.
2. Petri, W.A. Jr, Miller, M., Binder, H.J., Levine, M.M., Dillingham, R., and Guerrant, R.L. (2008) Enteric infections, diarrhea, and their impact on function and development. J. Clin. Invest., 118, 1277-1290.
3. DuPont, H.L., Chappell, C.L., Sterling, C.R., Okhuysen, P.C., Rose, J.B., and Jakubowski, W. (1995) The infectivity of Cryptosporidium parvum in healthy volunteers. N. Engl. J.Med., 332, 855-859.
4. Hunter, P.R. and Nichols, G. (2002) Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin. Microbiol. Rev., 15, 145-154.
5. Carey, C.M., Lee, H., and Trevors, J.T. (2004) Biology, persistence and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst. Water Res., 38, 818-862.
6. Arrowood, M.J. and Sterling, C.R. (1987) Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J. Parasitol., 73, 314-319.
7. Upton, S.J. (1997) In vitro cultivation, in Cryptosporidium and Cryptosporidiosis (ed R. Fayer), CRC Press, Boca Raton, pp. 181-207.
8. Fayer, R. (2004) Cryptosporidium: a water-borne zoonotic parasite. Vet. Parasitol., 126, 37-56.
9. Striepen, B., White, M.W., Li, C., Guerini, M.N., Malik, S.B. et al. (2002) Genetic complementation in apicomplexan parasites. Proc. Natl Acad. Sci. USA, 99, 6304-6309.
10. Striepen, B., Pruijssers, A.J.,Huang, J., Li, C., Gubbels, M.J., Umejiego, N.N. et al. (2004) Gene transfer in the evolution of parasite nucleotide biosynthesis. Proc. Natl Acad. Sci. USA, 101, 3154-3159.
11. Hedstrom, L. (2009) IMP dehydrogenase: structure, mechanism and inhibition. Chem. Rev., 109, 2903-2928.
12. Umejiego, N.N., Li, C., Riera, T., Hedstrom, L., and Striepen, B. (2004) Cryptosporidium parvum IMP dehydrogenase: Identification of functional, structural and dynamic properties that can be exploited for drug design. J. Biol. Chem., 279, 40320-40327.
13. Hedstrom, L. and Gan, L. (2006) IMP dehydrogenase: structural schizophrenia and an unusual base. Curr. Opin. Chem. Biol., 10, 520-525.
14. Riera, T.V., Wang, W., Josephine, H.R., and Hedstrom, L. (2008) A kinetic alignment of orthologous inosine-50-monophosphate dehydrogenases. Biochemistry, 47, 8689-8696.
15. Umejiego, N.N., Gollapalli, D., Sharling, L.,Volftsun, A., Lu, J. et al. (2008) Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis. Chem. Biol., 15, 70-77.
16. Sharling, L., Liu, X., Gollapalli, D.R., Maurya, S.K., Hedstrom, L., and Striepen, B. (2010) A screening pipeline for antiparasitic agents targeting Cryptosporidium inosine monophosphate dehydrogenase. PLoS Negl. Trop. Dis., 4, e794.
17. Maurya, S.K., Gollapalli, D.R., Kirubakaran, S., Zhang, M., Johnson, C.R. et al. (2009) Triazole inhibitors of Cryptosporidium parvum inosine 50-monophosphate dehydrogenase. J. Med. Chem., 52, 4623-4630.
18. MacPherson, I.S., Kirubakaran, S., Gorla, S.K., Riera, T.V., D'Aquino, J.A. et al. (2010) The structural basis of Cryptosporidium-specific IMP dehydrogenase inhibitor selectivity. J. Am. Chem. Soc., 132, 1230-1231.
19. Sintchak, M.D., Fleming, M.A., Futer, O., Raybuck, S.A., Chambers, S.P. et al. (1996) Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell, 85, 921-930.
20. Shahiduzzaman, M., Dyachenko, V., Obwaller, A., Unglaube, S., and Daugschies, A. (2009) Combination of cell culture and quantitative PCR for screening of drugs against Cryptosporidium parvum. Vet. Parasitol., 162, 271-277.
21. MacDonald, L.M., Sargent, K., Armson, A., Thompson, R.C., and Reynoldson, J.A. (2002) The development of a real-time quantitative-PCR method for characterisation of a Cryptosporidium parvum in vitro culturing system and assessment of drug efficacy. Mol. Biochem. Parasitol., 121, 279-282.
22. Cai, X., Woods, K.M., Upton, S.J., and Zhu, G. (2005) Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro. Antimicrob. Agents Chemother., 49, 4437-4442.
23. Di Giovanni, G.D. and LeChevallier, M.W. (2005) Quantitative-PCR assessment of Cryptosporidium parvum cell culture infection. Appl. Environ. Microbiol., 71, 1495-1500.
24. Fontaine, M. and Guillot, E. (2002) Development of a TaqMan quantitative PCR assay specific for Cryptosporidium parvum. FEMS Microbiol. Lett., 214, 13-17.
25. Godiwala, N.T., Vandewalle, A., Ward, H.D., and Leav, B.A. (2006) Quantification of in vitro and in vivo Cryptosporidiumparvum infection by using real-time PCR. Appl. Environ. Microbiol., 72, 4484-4488.
26. Gubbels, M.J. and Striepen, B. (2004) Studying the cell biology of apicomplexan parasites using fluorescent proteins. Microsc. Microanal., 10, 568-579.
27. Abrahamsen, M.S., Templeton, T.J., Enomoto, S., Abrahante, J.E., Zhu, G. et al. (2004) Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science, 304, 441-445.
28. Xu, P., Widmer, G.,Wang, Y., Ozaki, L.S., Alves, J.M. et al. (2004) The genome of Cryptosporidium hominis. Nature, 431, 1107-1112.
29. Vasquez, J.R., Gooze, L., Kim, K., Gut, J., Petersen, C., and Nelson, R.G. (1996) Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductasethymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum. Mol. Biochem. Parasitol., 79, 153-165.
30. De Clercq, E. (2004) Antiviral drugs in current clinical use. J. Clin. Virol., 30, 115-133.
31. Sun, X.E., Sharling, L., Muthalagi, M., Mudeppa, D.G., Pankiewicz, K.W. et al. (2010) Prodrug activation by Cryptosporidium thymidine kinase. J. Biol. Chem., 285, 15916-15922.
32. Temmink O.H., Emura, T., de Bruin, M., Fukushima, M., and Peters, G.J. (2007) Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies. Cancer Sci., 98, 779-789.
33. Emura, T., Suzuki, N., Fujioka, A., Ohshimo, H., and Fukushima, M. (2005) Potentiation of the antitumor activity of alpha, alpha, alpha-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo. Int. J. Oncol., 27, 449-455.
34. Yin, M.B. and Rustum, Y.M. (1991) Comparative DNA strand breakage induced by FUra and FdUrd in human ileocecal adenocarcinoma (HCT-8) cells: relevance to cell growth inhibition. Cancer Commun., 3, 45-51.
35. Zhang, J., Visser, F., King, K.M., Baldwin, S.A., Young, J.D., and Cass, C.E. (2007) The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer Metastasis Rev., 26, 85-110.
36. Lavie, A. and Konrad, M. (2004) Structural requirements for efficient phosphorylation of nucleotide analogs by human thymidylate kinase. Mini Rev.Med. Chem., 4, 351-359.
37. Woods, K.M. and Upton, S.J. (1998) Efficacy of select antivirals against Cryptosporidium parvum in vitro. FEMS Microbiol. Lett., 168, 59-63.
38. Xu, P., Widmer, G.,Wang, Y., Ozaki, L.S., Alves, J.M. et al. (2004) The genome of Cryptosporidium hominis. Nature, 431, 1107-1112.
39. Zhu, G., Marchewka, M.J., and Keithly, J.S. (2000) Cryptosporidium parvum appears to lack a plastid genome. Microbiology, 146Pt (2), 315-321.
40. Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M. et al. (2004) UCSF Chimera - a visualization system for exploratory research and analysis. J. Comp. Chem., 25, 1605-1612.